Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.
GSK plans to sell off remaining stake in consumer spinout Haleon
British drugmaker GSK will sell off the rest of its share in Haleon after slowly selling off multibillion-dollar pieces of its ownership in the consumer